ImmuCell Corporation
News
ImmuCell Co. (NASDAQ:ICCC) Short Interest Down 40.5% in August
Ticker Report ImmuCell Co. (NASDAQ:ICCC - Get Free Report) was the target of a significant drop in short interest in August. As of August 15th, there was short interest totalling 2,500 shares, a drop of 40.5% from...\n more…
ImmuCell Second Quarter 2024 Earnings: US$0.20 loss per share (vs US$0.18 loss in 2Q 2023)
Simply Wall St ImmuCell ( NASDAQ:ICCC ) Second Quarter 2024 Results Key Financial Results Revenue: US$5.47m (up 55% from 2Q 2023). Net...\n more…
ImmuCell GAAP EPS of -$0.20, revenue of $5.5M
SeekingAlpha.com: All News ImmuCell (ICCC) reports Q2 GAAP EPS of -$0.20 and revenue of $5.5M, a 55.8% increase year over year.\n more…
ICCC Stock Earnings: ImmuCell Beats Revenue for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nICCC stock results show that ImmuCell beat on revenue for the second quarter of 2024.\nThe post ICCC Stock Earnings: ImmuCell Beats...\n more…
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
Globe Newswire PORTLAND, Maine, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ( ImmuCell or the Company ), a growing animal health company that develops, manufactures and markets...\n more…
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024
Globe Newswire Conference Call Scheduled for Wednesday, August 14, 2024 at 9:00 AM ETPORTLAND, Maine, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ( ImmuCell or the Company ), a growing...\n more…